We engaged in exploring the pathogenesis and treatment of acute respiratory distress syndrome (ARDS) induced by sepsis for several years. The pathogenesis of ARDS is complex, and is currently believed to involve loss of control over inflammatory responses in lung tissue. Our research interest was to clarify the effect and mechanism of norepinephrine and other neurotransmitters released by sympathetic stress in ARDS. The role of the sympathetic nervous system in regulating inflammation is a topic of current research efforts. And alveolar macrophages are a critical factor in pulmonary inflammation during ARDS. Now we have found that norepinephrine could improve lung injury by inhibiting the inflammatory reaponse of alveolar macrophage, and α2A-adrenoceptor subtype might have play an important role during this process. Blockade of α2A-adrenoceptor could inhibit systemic inflammatory responses and mitigate acute lung injury in septic rats and mice. Currently, we are still focusing on the role of different adrenergic receptors in ARDS. Furthermore, we want to further clarify the specific roles of these different receptors in ARDS, and what is the mechanism of them.